Global Cold Chain AeroSafe Global operates in 80 countries with the capacity to deliver 11 million shipments annually, indicating a broad international footprint and scalable cold-chain capabilities that can be leveraged to expand into new markets or support global partnerships.

CCaaS Advantage Their proprietary Cold Chain as a Service platform combines end-to-end logistics, packaging technology, and reuse programs, offering a differentiated value proposition that can be pitched to pharmaceutical manufacturers and distributors seeking reliability, cost efficiency, and sustainability.

Strong Partnerships Recent collaborations with MD Logistics, MassBio, BioCare, and a notable EY Entrepreneur of the Year award for the CEO enhance credibility with potential customers and channel partners, signaling ripe opportunities for co-selling and integration discussions.

Sustainability Focus Full-cycle reuse programs and reduced product loss address environmental and operational cost reductions, providing a compelling angle for customers prioritizing sustainability, regulatory compliance, and waste minimization within their supply chains.

Growth & Investment Revenue is in the high hundreds of millions with substantial funding, and recognition as a fast-growing technology provider position AeroSafe as an attractive partner for strategic buyers, private equity-backed distributors, and large-scale 3PLs seeking innovative cold-chain solutions.